Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1982 Nov;58(685):701–703. doi: 10.1136/pgmj.58.685.701

A clinical trial of levamisole in primary biliary cirrhosis.

S Hishon, G Tobin, P J Ciclitira
PMCID: PMC2426569  PMID: 6763217

Abstract

A small pilot study of levamisole in primary biliary cirrhosis failed to demonstrate any improvement in liver function and immunological abnormalities even in 'early' cases. This may be due to the fact that the defect in the immune system lies in its afferent arm. At present, levamisole, which is potentially toxic, cannot be recommended in conventional doses for the treatment of this disease.

Full text

PDF
701

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CARMAN C. T., GIANSIRACUSA J. E. Effect of steroid therapy on the clinical and laboratory features of primary biliary cirrhosis. Gastroenterology. 1955 Feb;28(2):193-207; discussion, 208-15. [PubMed] [Google Scholar]
  2. Feizi T. Immunoglobulins in chronic liver disease. Gut. 1968 Apr;9(2):193–198. doi: 10.1136/gut.9.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fox R. A., Scheuer P. J., Sherlock S. Asymptomatic primary biliary cirrhosis. Gut. 1973 Jun;14(6):444–447. doi: 10.1136/gut.14.6.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harkiss G. D., Brown D. L. Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC). Clin Exp Immunol. 1979 Apr;36(1):117–129. [PMC free article] [PubMed] [Google Scholar]
  5. Heathcote J., Ross A., Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology. 1976 May;70(5 PT1):656–660. [PubMed] [Google Scholar]
  6. Howat H. T., Ralston A. J., Varley H., Wilson J. A. The late results of long-term treatment of primary biliary cirrhosis by corticosteroids. Rev Int Hepatol. 1966;16(2):227–238. [PubMed] [Google Scholar]
  7. MacSween R. N., Galbraith I., Thomas M. A., Watkinson G., Ludlam G. B. Phytohaemagglutinin (PHA) induced lymphocyte transformation and Toxoplasma gondii antibody studies in primary biliary cirrhosis. Evidence of impaired cell-mediated immunity. Clin Exp Immunol. 1973 Sep;15(1):35–42. [PMC free article] [PubMed] [Google Scholar]
  8. RUBIN E., SCHAFFNER F., POPPER H. PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS. Am J Pathol. 1965 Mar;46:387–407. [PMC free article] [PubMed] [Google Scholar]
  9. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med. 1967 Dec;60(12):1257–1260. [PMC free article] [PubMed] [Google Scholar]
  10. Sherlock S., Fox R. A., James D. G., Scheuer P. J., Sharma O. Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet. 1969 May 10;1(7602):959–962. doi: 10.1016/s0140-6736(69)91860-1. [DOI] [PubMed] [Google Scholar]
  11. Thomas H. C., Potter B. J., Sherlock S. Is primary biliary cirrhosis an immune complex disease? Lancet. 1977 Dec 17;2(8051):1261–1263. doi: 10.1016/s0140-6736(77)92666-6. [DOI] [PubMed] [Google Scholar]
  12. WALKER J. G., DONIACH D., ROITT I. M., SHERLOCK S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. doi: 10.1016/s0140-6736(65)91372-3. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES